Waldencast plc-Waldencast Reports Q3 2024 Financial Results

$70.2 million of Net Revenue Q3 2024 +34.6% Comparable Net Revenue Growth Both brands accelerating from Q2 2024 +45.5% Obagi Medical and +23.5% Milk Makeup vs Q3 2023 Adjusted EBITDA of$ 11.4 million, up +134.0% vs Q3 2023 LONDON, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today reported operating results for the three months ended September 30, 2024 ("Q3 2024") and nine months ended September 30, 2024 ( ...